ASML: €50+ Billion In EBIT By 2030? Wall Street Is Still Behind
Source: seekingalpha.com

ASML reported Q3 sales of €11.66B, a 57.5% gross margin and €4.96B in net income. Equipment demand is ahead of planned capacity through 2027–28, with customers already asking about 2029/2030 orders. Secured price increases on critical products are expected to structurally lift margins, with the full benefit beginning in 2028.
Analysis
The key economic signal is a shift in bargaining power: if customers accept higher prices while ASML remains capacity-constrained, incremental economics could improve without equivalent unit growth. But the margin benefit is back-ended, so near-term valuation can outrun realized earnings if investors capitalize the 2028 uplift too aggressively. The other side of that pricing power is customer ROI pressure: foundries and chipmakers may stretch tool utilization, stage installations, or redirect some investment, even if long-dated reservations remain strong.
Over the next 1–3 months, watch order conversion, shipment timing, and customer capex guidance—not inquiry volume alone. Over 6–18 months, export restrictions and any pause in leading-edge fab plans are the main threats to translating a long order horizon into delivered revenue. Capacity at critical suppliers is also a potential constraint: ASML cannot monetize demand faster than its own and its suppliers’ delivery capacity allows.
The contrarian risk is that a strong long-range demand narrative may obscure cyclicality and the gap between customer interest and firm, deliverable orders. The upside case is that price realization proves durable and lifts margins as scheduled; the downside is delayed deliveries or order revisions before the price benefit reaches reported results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment
Key Decisions for Investors
- For a 6–18 month horizon, consider building ASML exposure on weakness rather than chasing a near-term earnings reaction; the thesis is pricing power plus sustained leading-edge investment, not simply a long backlog.
- Keep the position sized for semiconductor-capex cyclicality. Reassess if customer capex plans weaken, orders are deferred or cancelled, or ASML indicates that supplier capacity is limiting shipments more than expected.
- Track realized price increases and gross-margin progression against the stated timing. If the margin trajectory fails to strengthen as the benefit approaches, the distant earnings uplift may be overcapitalized.
- Treat export-control changes and customer spending plans as event risks; avoid adding on long-dated inquiries alone until they convert into firm orders and scheduled deliveries.
More News
- AI Capex, Gamble or Jackpot?: Market Snapshot
- I watched Nvidia's Jensen Huang work the room in London. He brought big checks — and a blunt message
- ‘I told you so’: China’s chip sector is making breakthroughs—and U.S. export controls are the reasons why
- Why is BE Semiconductor Industries stock sliding today?
- European stocks on course for best week since Aug on easing yields
- ASML: An Earnings Monster With More Room To Run